Skip to main content
Caplight Logo









Sonmol

Sonmol

Private
ShanghaiHealthcare & Life Scienceshttps://www.sonmol.com/

Last Round

Strategic

Jul 18, 2024

Est. Valuation

$367.08M

Total Funding Raised

$173.68M

Company Overview

Sonmol is a digital health company that develops AI-powered respiratory disease management platforms and connected medical devices for the diagnosis and treatment of conditions such as asthma and COPD.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Telemedicine, Patient Engagement

Business Model

B2C

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

remote patient monitoringRPMdigital healthrespiratory managementconnected healthspirometerpeak flow metersmart nebulizertelemedicinemedical IoTchronic disease managementhealth techOEM medical devicesclinical decision support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sonmol Comparables

Compare Sonmol with similar companies based on industry and business-model similarity.

Sonmol comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ResMed Inc
83%
Cohero Health, Inc.
78%
Adherium Limited
77%

Sonmol Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJul 18, 2024
Series E ExtensionAug 19, 2022
Series ENov 1, 2021
Series DDec 22, 2020
Series CAug 1, 2019
Series B Extension
Oct 22, 2018

Sonmol Investors

Notable investors and investment history

Sonmol investors
InvestorRounds
IDG CapitalSeries E
ZhenFundSeries B, Angel
健壹资本Series C
Shanghai Shengyu Equity Investment Fund ManagementSeries E
CRCM VenturesAngel
Sunshine Insurance GroupSeries D
CICC ALPHASeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 18, 2024

    $8.3M raised from Changchun City Equity Investment Fund Management Co., Ltd.

  • Aug 19, 2022

    Completed a Series E Extension round of funding.

Sonmol Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sonmol Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sonmol's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Year Founded2014
Last FundingJul 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?